National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

methylnaltrexone (MEH-thul-nal-TREK-sone)

 The active ingredient in a drug used to relieve certain side effects caused by treatment with opiods (pain killers similar to morphine), such as constipation (hard, dry stools), itching, and low urine flow. Methylnaltrexone binds to opioid receptors outside the brain and may block the side effects of opioid drugs without affecting their ability to relieve pain. Methylnaltrexone is a type of peripheral opioid receptor antagonist.



Previous Definitions:methodology, methotrexate, methoxsalen, methoxypolyethylene glycol epoetin beta, methyl-5-aminolevulinate
Next Definitions:methylnaltrexone bromide, methylphenidate, methylprednisolone, metoclopramide, metronidazole

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov